ImmuCell Corporation Royalty Expense
ImmuCell Corporation (ICCC) reported Royalty Expense of $36.00 thousand for the 36-month period ending 2018-12-31, per its 10-K filed 2020-03-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2020-03-27
- ImmuCell Corporation royalty expense for the quarter ending 2018-12-31 was $5.22K, a 38.18% increase year-over-year.
- ImmuCell Corporation royalty expense for the quarter ending 2018-09-30 was $3.69K, a 89.87% increase year-over-year.
- ImmuCell Corporation royalty expense for the quarter ending 2017-12-31 was $3.78K.
- ImmuCell Corporation royalty expense for the quarter ending 2017-09-30 was $1.94K.
- ImmuCell Corporation royalty expense for fiscal 2018 was $17.27K, a 62.68% increase from fiscal 2017.
- ImmuCell Corporation royalty expense for fiscal 2017 was $10.62K, a 29.45% increase from fiscal 2016.
- ImmuCell Corporation royalty expense for fiscal 2016 was $8.20K.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month | Royalty Expense 36 month |
|---|---|---|---|---|---|
| 2018-12-31 | $5.22K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $8.91K derived: sum of 2 quarters · filed 2019-03-22 | $17.27K 10-K · filed 2019-03-22 | $36.00K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $3.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $12.05K 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | $8.36K 10-Q · filed 2018-08-13 | ||||
| 2017-12-31 | $3.78K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $5.72K derived: sum of 2 quarters · filed 2019-03-22 | $10.62K 10-K · filed 2019-03-22 | ||
| 2017-09-30 | $1.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $6.84K 10-Q · filed 2018-11-13 | |||
| 2017-06-30 | $4.89K 10-Q · filed 2018-08-13 | ||||
| 2016-12-31 | $8.20K 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |